Biohacking to Better Health
SHARE | PRINT | EMAIL
Perhaps with regards to healthspan and lifespan, instead of calorie restriction, we can bio-hack through either eating as much as we want once a day, or eating ... Read more.
Isabella D. Cooper is a human clinical trials Doctoral researcher. She leads a lab at the University of Westminster processes research at all stages from in vivo, to ex vivo and in vitro investigations. She majored in biochemistry and medical pathology, focusing on ageing biology, ketosis, hyperinsulinemia, and chronic diseases associated with ageing. Isabella’s PhD elucidated the first full spectrum metabolic, endocrine, lipidology LDL responses and extracellular vesicles phenotypes, in cross-over clinical trials with participants in different metabolic states. She published a diagnostic grading scale for metabolic phenotypes and classified and named the disease Hyperinsulinaemia-Osteofragilitus. She is a Fellow of The Royal Society of Biology and the Endocrine Society with a BSc (Hons) in Biochemistry with Medical Physiology, Molecular Genetics, Advanced Cell and Cancer Biology, and multiple academic achievements including the UK 2019 Biochemical Society Award.